Société de Therapeutique Marocaine S.A.

CBSE:SOT Stock Report

Market Cap: د.م7.2b

Société de Therapeutique Marocaine Future Growth

Future criteria checks 0/6

Société de Therapeutique Marocaine's EPS is expected to grow by 15.5% per annum.

Key information

n/a

Earnings growth rate

15.5%

EPS growth rate

Pharmaceuticals earnings growth17.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

CBSE:SOT - Analysts future estimates and past financials data (MAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20232,33626060143N/A
3/31/20232,31926473150N/A
12/31/20222,30226786156N/A
9/30/20222,268286129197N/A
6/30/20222,233306173237N/A
3/31/20222,145293219282N/A
12/31/20212,056279265328N/A
9/30/20211,998264199258N/A
6/30/20211,940249133189N/A
3/31/20211,86924084141N/A
12/31/20201,7982303594N/A
9/30/20201,737233N/AN/AN/A
6/30/20201,675235N/AN/AN/A
3/31/20201,680227N/AN/AN/A
12/31/20191,686220155227N/A
9/30/20191,647173N/AN/AN/A
6/30/20191,667196N/AN/AN/A
3/31/20191,629207N/AN/AN/A
12/31/20181,561182111163N/A
9/30/20181,544208N/AN/AN/A
6/30/20181,497198N/AN/AN/A
3/31/20181,456174N/AN/AN/A
12/31/20171,415150132193N/A
9/30/20171,400153N/AN/AN/A
6/30/20171,386155N/AN/AN/A
3/31/20171,356152N/AN/AN/A
12/31/20161,326149N/A190N/A
9/30/20161,261135N/AN/AN/A
6/30/20161,195121N/AN/AN/A
3/31/20161,175119N/AN/AN/A
12/31/20151,156118N/A161N/A
9/30/20151,155115N/AN/AN/A
6/30/20151,155113N/AN/AN/A
3/31/20151,138102N/AN/AN/A
12/31/20141,12292N/A137N/A
9/30/20141,12595N/AN/AN/A
6/30/20141,12997N/AN/AN/A
3/31/20141,124107N/AN/AN/A
12/31/20131,119117N/A159N/A
9/30/20131,093118N/AN/AN/A
6/30/20131,066118N/AN/AN/A
3/31/20131,043107N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SOT's forecast earnings growth is above the savings rate (14%).

Earnings vs Market: Insufficient data to determine if SOT's earnings are forecast to grow faster than the MA market

High Growth Earnings: Insufficient data to determine if SOT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SOT's revenue is forecast to grow faster than the MA market.

High Growth Revenue: Insufficient data to determine if SOT's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SOT's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.